Qarziba Conc For Soln For Infu 4.5 Mg/Ml 4.5Ml (Dinutuximab Beta) Formulation

臺北榮民總醫院 Taiwan has Released a tender for Qarziba Conc For Soln For Infu 4.5 Mg/Ml 4.5Ml (Dinutuximab Beta) Formulation in Healthcare and Medicine. The tender was released on Dec 05, 2024.

Country - Taiwan

Summary - Qarziba Conc For Soln For Infu 4.5 Mg/Ml 4.5Ml (Dinutuximab Beta) Formulation

Deadline - login to view

MT reference number - 99119304

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

  Address - Taiwan

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 99119304

  Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: Qarziba Conc For Soln For Infu 4.5 Mg/Ml 4.5Ml (Dinutuximab Beta) Formulationlocal title:: Qarziba conc for soln for infu 4.5 mg/mL 4.5ml (Dinutuximab beta)壹批Contract Type: : Service Medical Tenders is not only confined to tenders but we also upload crucial information, from future prospects to past market records.

Mt Ref Id - 99119304

Deadline - Nov 30, -0001

Share

Similar Tenders :